DMK PHARMACEUTICALS Corp

2023 Q4 Form 10-Q Financial Statement

#000199937123000197 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.664M
YoY Change 175.37%
Cash & Equivalents $6.664M
Short-Term Investments
Other Short-Term Assets $67.21K
YoY Change -98.66%
Inventory $663.0K
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $7.872M
YoY Change -21.97%
LONG-TERM ASSETS
Property, Plant & Equipment $1.076M
YoY Change -32.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.674K
YoY Change -81.46%
Total Long-Term Assets $1.085M
YoY Change -47.03%
TOTAL ASSETS
Total Short-Term Assets $7.872M
Total Long-Term Assets $1.085M
Total Assets $8.957M
YoY Change -26.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.973M
YoY Change 88.26%
Accrued Expenses $2.324M
YoY Change 73.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.46M
YoY Change 51.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $459.6K
YoY Change 76.46%
Total Long-Term Liabilities $459.6K
YoY Change 76.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.46M
Total Long-Term Liabilities $459.6K
Total Liabilities $13.92M
YoY Change 52.41%
SHAREHOLDERS EQUITY
Retained Earnings -$323.5M
YoY Change 7.38%
Common Stock $318.2M
YoY Change 4.63%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.250K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$5.295M
YoY Change
Total Liabilities & Shareholders Equity $8.957M
YoY Change -26.2%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Entity Central Index Key
EntityCentralIndexKey
0000887247
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q3 dmk Product Recall Liability Current
ProductRecallLiabilityCurrent
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
usd
CY2022Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
usd
us-gaap Interest Expense
InterestExpense
usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q3 dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
usd
CY2022Q3 dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
usd
dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
usd
dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
usd
us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
usd
dmk Payments Of Financing Issuance Costs
PaymentsOfFinancingIssuanceCosts
usd
dmk Proceeds From Common Warrant Exercises
ProceedsFromCommonWarrantExercises
usd
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
usd
dmk Issuance Of Common Stock For Merger
IssuanceOfCommonStockForMerger
usd
dmk Issuance Of Preferred Stock For Merger
IssuanceOfPreferredStockForMerger
usd
dmk Options Assumed And Replaced In Connection With Merger
OptionsAssumedAndReplacedInConnectionWithMerger
usd
dmk Increase Decrease In Accrued Capital Expenditures
IncreaseDecreaseInAccruedCapitalExpenditures
usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
dmk Cashless Exercise Of Prefunded Warrants
CashlessExerciseOfPrefundedWarrants
usd
dmk Exercise Of Prefunded Warrants
ExerciseOfPrefundedWarrants
usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663921 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1081364 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1388046 usd
us-gaap Net Income Loss
NetIncomeLoss
-18905075 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323469161 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
usd
CY2023Q3 dmk Accumulated Loss On Classification As Held For Sale
AccumulatedLossOnClassificationAsHeldForSale
usd
CY2023Q3 dmk Disposal Group Including Discontinued Operation Contingent Loss Liability
DisposalGroupIncludingDiscontinuedOperationContingentLossLiability
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Liabilities
DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
usd
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
CY2022Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
dmk Disposal Group Including Discontinued Operation Impairment Of Fixed Assets
DisposalGroupIncludingDiscontinuedOperationImpairmentOfFixedAssets
usd
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
usd
CY2023Q3 dmk Employee Retention Credit
EmployeeRetentionCredit
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36242
dei Entity Registrant Name
EntityRegistrantName
DMK PHARMACEUTICALS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0429727
dei Entity Address Address Line1
EntityAddressAddressLine1
11622 El Camino Real
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
(858)
dei Local Phone Number
LocalPhoneNumber
997-2400
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
DMK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10102050 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663921 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1081364 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
30068 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1054058 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
662962 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1238778 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
539772 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1914966 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5406 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
3952916 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
7872061 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9272150 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1075676 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288894 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
317622 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9674 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52174 usd
CY2023Q3 us-gaap Assets
Assets
8957411 usd
CY2022Q4 us-gaap Assets
Assets
10930840 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9973413 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7937493 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
172779 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
27779 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8957411 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2323738 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1510053 usd
CY2022Q4 dmk Product Recall Liability Current
ProductRecallLiabilityCurrent
305806 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
63209 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
342562 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
929328 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1272173 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13462467 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11395866 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
157413 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
178247 usd
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
302170 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7492 usd
CY2023Q3 us-gaap Liabilities
Liabilities
13922050 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11581605 usd
CY2023Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
330000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
157303 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10102050 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2150051 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10094580 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2142581 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1010 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
215 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
318178762 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
303761053 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323469161 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304564086 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7470 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7470 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5250 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5250 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5294639 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-808068 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10930840 usd
CY2023Q3 us-gaap Revenues
Revenues
9062 usd
CY2022Q3 us-gaap Revenues
Revenues
1505683 usd
us-gaap Revenues
Revenues
1469007 usd
us-gaap Revenues
Revenues
2605396 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
338488 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1647585 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2487948 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3705697 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-329426 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-141902 usd
us-gaap Gross Profit
GrossProfit
-1018941 usd
us-gaap Gross Profit
GrossProfit
-1100301 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2517161 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2508176 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11332333 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10096807 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
418518 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1977939 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2106004 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9520118 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6539675 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3265105 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4628017 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20996953 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20717226 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13835 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
19699 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
14549 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
40021 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
29465 usd
us-gaap Interest Expense
InterestExpense
135808 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
773764 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
278419 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1183781 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-419413 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1787417 usd
dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
2476109 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-770723 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-58690 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4656292 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-87618 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1528857 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
356808 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3242705 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2079191 usd
CY2023Q3 dmk Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
40 usd
CY2023Q3 dmk Stock Issued During Period Value Exercise Of Common Warrants
StockIssuedDuringPeriodValueExerciseOfCommonWarrants
870750 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-44693 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1736248 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4271209 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-17754248 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22796417 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
348202 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-127692 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1150827 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-354320 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1388046 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4398901 usd
us-gaap Net Income Loss
NetIncomeLoss
-18905075 usd
us-gaap Net Income Loss
NetIncomeLoss
-23150737 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.25
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.25
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.99
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.99
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-4.53
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-4.53
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-10.65
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-10.65
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.29
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.29
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.17
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.82
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.82
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7065673 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7065673 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2142618 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2142618 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3957733 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3957733 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2140097 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2140097 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-11825326 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
912751 usd
CY2023Q3 dmk Stock And Warrants Issued During Period Value New Issues
StockAndWarrantsIssuedDuringPeriodValueNewIssues
7092636 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1388046 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5294639 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-808068 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
172697 usd
dmk Convertible Preferred Stock Issued During Period Value Acquisitions
ConvertiblePreferredStockIssuedDuringPeriodValueAcquisitions
4853000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
757038 usd
dmk Adjustments To Additional Paid In Capital Stock Options Assumed Pursuant To Merger
AdjustmentsToAdditionalPaidInCapitalStockOptionsAssumedPursuantToMerger
415809 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
912751 usd
dmk Stock And Warrants Issued During Period Value New Issues
StockAndWarrantsIssuedDuringPeriodValueNewIssues
7092636 usd
dmk Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
525169 usd
dmk Stock Issued During Period Value Exercise Of Common Warrants
StockIssuedDuringPeriodValueExerciseOfCommonWarrants
870750 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76799 usd
us-gaap Net Income Loss
NetIncomeLoss
-18905075 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5294639 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7042143 usd
CY2022Q3 dmk Temporary Equity Stock Issued During Period Issuance Costs
TemporaryEquityStockIssuedDuringPeriodIssuanceCosts
8300 usd
CY2022Q3 dmk Number Of Warrants Issued
NumberOfWarrantsIssued
750000 shares
CY2022Q3 dmk Warrants Issuance Costs
WarrantsIssuanceCosts
6700 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
127697 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74488 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4398901 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2845427 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25882778 usd
dmk Temporary Equity Stock Issued During Period Issuance Costs
TemporaryEquityStockIssuedDuringPeriodIssuanceCosts
8300 usd
dmk Number Of Warrants Issued
NumberOfWarrantsIssued
750000 shares
dmk Warrants Issuance Costs
WarrantsIssuanceCosts
6700 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
127697 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-14311 usd
us-gaap Net Income Loss
NetIncomeLoss
-23150737 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2845427 usd
us-gaap Net Income Loss
NetIncomeLoss
-18905075 usd
us-gaap Net Income Loss
NetIncomeLoss
-23150737 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1150827 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-354320 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6539675 usd
us-gaap Share Based Compensation
ShareBasedCompensation
76799 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-14311 usd
dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
2476109 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4656292 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-87618 usd
dmk Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
-78665 usd
dmk Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
-12081 usd
us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
116934 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
264012 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1111495 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-919413 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1054058 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
490940 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-575816 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
673838 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1318090 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-567094 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1580139 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1319707 usd
dmk Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
-305806 usd
dmk Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
-1591870 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-22952 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-637030 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1108448 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1552766 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7707883 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23939162 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-145429 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-439301 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7853312 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24378463 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
588923 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
136089 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
12104 usd
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
3917530 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
148193 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3328607 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2599267 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2747460 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3328607 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2099862 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
899388 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
275000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
790 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
8005387 usd
dmk Payments Of Financing Issuance Costs
PaymentsOfFinancingIssuanceCosts
912751 usd
dmk Proceeds From Common Warrant Exercises
ProceedsFromCommonWarrantExercises
870750 usd
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
285000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10688426 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
285000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10688426 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
285000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5582574 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20764856 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1111432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23250793 usd
dmk Change In Cash And Cash Equivalents Of Discontinued Operations
ChangeInCashAndCashEquivalentsOfDiscontinuedOperations
-30085 usd
dmk Change In Cash And Cash Equivalents Of Discontinued Operations
ChangeInCashAndCashEquivalentsOfDiscontinuedOperations
-35921 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6663921 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2450016 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663921 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2419960 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
30056 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6663921 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2450016 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3625 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
157461 usd
dmk Issuance Of Common Stock For Merger
IssuanceOfCommonStockForMerger
757038 usd
dmk Issuance Of Preferred Stock For Merger
IssuanceOfPreferredStockForMerger
4853000 usd
dmk Options Assumed And Replaced In Connection With Merger
OptionsAssumedAndReplacedInConnectionWithMerger
415809 usd
dmk Increase Decrease In Accrued Capital Expenditures
IncreaseDecreaseInAccruedCapitalExpenditures
217340 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
172697 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
73 usd
dmk Cashless Exercise Of Prefunded Warrants
CashlessExerciseOfPrefundedWarrants
73 usd
dmk Exercise Of Prefunded Warrants
ExerciseOfPrefundedWarrants
524379 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-70
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z5dQ4YTxOcVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i><span style="text-decoration: underline">Prior Periods Reclassifications</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Certain amounts in prior periods have been reclassified to conform with current period presentation related to the receivable from Fagron included in prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets. Such reclassification had no effect on the total current assets as of December 31, 2022. The reclassification had no effect on the condensed consolidated statement of operations or condensed consolidated statement of cash flows for the periods ended September 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Certain amounts in prior periods have been reclassified to conform with current period presentation related to interest income which was presented separately from the other income (expenses) on the accompanying condensed consolidated statements of operations. Such reclassification had no effect on the total other income (expense), net for the three and nine months ended September 30, 2022. The reclassification had no effect on the condensed consolidated balance sheet as of December 31, 2022 or condensed consolidated statement of cash flows for the periods ended September 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="margin: 6pt 0in; line-height: normal; text-align: justify"><em></em></p> <p><em> </em></p>
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
27138 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1150827 usd
CY2023Q3 dmk Accrued Expenses Research And Development
AccruedExpensesResearchAndDevelopment
145806 usd
CY2022Q4 dmk Accrued Expenses Research And Development
AccruedExpensesResearchAndDevelopment
42400 usd
CY2023Q3 dmk Accrued Expenses Cost Of Goods Sold
AccruedExpensesCostOfGoodsSold
1392810 usd
CY2022Q4 dmk Accrued Expenses Cost Of Goods Sold
AccruedExpensesCostOfGoodsSold
1099571 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
601000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
200363 usd
CY2023Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
184122 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
167719 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2323738 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1510053 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1388046 usd
us-gaap Net Income Loss
NetIncomeLoss
-18905075 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
172697 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1388046 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19077772 usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
437339 usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
27138 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
30085 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
6719252 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Other Assets
DisposalGroupIncludingDiscontinuedOperationOtherAssets
5406 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Other Assets
DisposalGroupIncludingDiscontinuedOperationOtherAssets
5407 usd
CY2022Q4 dmk Accumulated Loss On Classification As Held For Sale
AccumulatedLossOnClassificationAsHeldForSale
2801828 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
5406 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
3952916 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
673335 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
649633 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
55959 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
75602 usd
CY2023Q3 dmk Disposal Group Including Discontinued Operation Lease Liabilities
DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities
200034 usd
CY2022Q4 dmk Disposal Group Including Discontinued Operation Lease Liabilities
DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities
243008 usd
CY2022Q4 dmk Disposal Group Including Discontinued Operation Contingent Loss Liability
DisposalGroupIncludingDiscontinuedOperationContingentLossLiability
50000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
208000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Tax Liabilities
DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities
45930 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
929328 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1272173 usd
CY2023Q3 dmk Disposal Group Including Discontinued Operation General And Administrative Expense Net
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpenseNet
20798 usd
CY2022Q3 dmk Disposal Group Including Discontinued Operation General And Administrative Expense Net
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpenseNet
125722 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
22 usd
CY2023Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
369000 usd
CY2022Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-1992 usd
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
348202 usd
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-127692 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
348202 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-127692 usd
dmk Disposal Group Including Discontinued Operation General And Administrative Expense Net
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpenseNet
83721 usd
dmk Disposal Group Including Discontinued Operation General And Administrative Expense Net
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpenseNet
390105 usd
dmk Disposal Group Including Discontinued Operation Impairment Of Fixed Assets
DisposalGroupIncludingDiscontinuedOperationImpairmentOfFixedAssets
1512263 usd
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
7818 usd
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
8647 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-354320 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-354320 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1150827 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-354320 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-354320 usd
CY2023Q3 dmk Product Recall Liability
ProductRecallLiability
0 usd
CY2022Q4 dmk Product Recall Liability
ProductRecallLiability
300000 usd
us-gaap Inventory Recall Expense
InventoryRecallExpense
2600000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
267554 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
261720 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
662962 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
709504 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
662962 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
1238778 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5156377 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5209575 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4080701 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4665067 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
744386 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1075676 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288894 usd
CY2023Q3 us-gaap Depreciation
Depreciation
67000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
399000 usd
us-gaap Depreciation
Depreciation
264000 usd
us-gaap Depreciation
Depreciation
1111000 usd
CY2022Q4 dmk Employee Retention Credit
EmployeeRetentionCredit
875307 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
86436 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
323143 usd
CY2023Q3 dmk Prepaid Research And Development
PrepaidResearchAndDevelopment
326854 usd
CY2022Q4 dmk Prepaid Research And Development
PrepaidResearchAndDevelopment
588354 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
59275 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
78590 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
67207 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
49572 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
539772 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1914966 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
463000 usd
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1414943.08 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000.0 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000 usd
CY2023Q1 dmk Excess Of Warrant Fair Value Over Offering Proceeds
ExcessOfWarrantFairValueOverOfferingProceeds
2476109 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2999250 usd
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
7100000 usd
CY2023Q3 dmk Payments Of Financing Issuance Costs
PaymentsOfFinancingIssuanceCosts
900000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-44693 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
74488 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76799 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-14311 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6184323 shares
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8366515 shares
CY2023Q3 us-gaap Cost Maintenance
CostMaintenance
268000 usd
us-gaap Cost Maintenance
CostMaintenance
804000 usd

Files In Submission

Name View Source Status
0001999371-23-000197-index-headers.html Edgar Link pending
0001999371-23-000197-index.html Edgar Link pending
0001999371-23-000197.txt Edgar Link pending
0001999371-23-000197-xbrl.zip Edgar Link pending
dmk-10q_093023.htm Edgar Link pending
dmk-20230930.xsd Edgar Link pending
ex10-7.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
dmk-20230930_def.xml Edgar Link unprocessable
dmk-20230930_lab.xml Edgar Link unprocessable
dmk-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dmk-10q_093023_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dmk-20230930_cal.xml Edgar Link unprocessable